检索历史清除

首页> Clinical cancer research: an official journal of the American Association for Cancer Research> Analyzing the pivotal trial that compared sunitinib and IFN-α in renal cell carcinoma, using a method that assesses tumor regression and growth

Analyzing the pivotal trial that compared sunitinib and IFN-α in renal cell carcinoma, using a method that assesses tumor regression and growth

导出原文传递

翻译打印收藏纠错

作者： Stein,W.D. ^[1] ; Wilkerson,J. ^[2] ; Kim,S.T. ^[3] ; Huang,X. ; Motzer,R.J. ; Fojo,A.T. ; Bates,S.E.

作者单位： Medical Oncology Branch, NCI, NIH, 9000 Rockville Pike, Bethesda, MD 20892, United States ^[1] Pfizer, Inc., San Diego, CA, United States ^[2] Memorial Sloan-Kettering Cancer Center, New York, NY, United States ^[3]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交